Geode Capital Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
13,328
+54
| +0.4% | +$575 | ﹤0.01% | 3973 |
|
|
2025
Q1 | $150K | Hold |
13,274
| – | – | ﹤0.01% | 3927 |
|
|
2024
Q4 | $139K | Buy |
13,274
+2,405
| +22% | +$25.3K | ﹤0.01% | 4003 |
|
|
2024
Q3 | $114K | Hold |
10,869
| – | – | ﹤0.01% | 4069 |
|
|
2024
Q2 | $111K | Hold |
10,869
| – | – | ﹤0.01% | 4110 |
|
|
2024
Q1 | $112K | Buy |
+10,869
| New | +$112K | ﹤0.01% | 4128 |
|